RETIPHARMA
RetiPharma is a Danish Biotech company that is developing products for treatment of degenerative eye disorders based on peptides that exerts neuroprotective effect in the eye.
RETIPHARMA
Industry:
Biotechnology Pharmaceutical
Founded:
2015-01-01
Address:
Copenhagen, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.retipharma.com
Total Employee:
1+
Status:
Active
Contact:
(+45) 30 30 40 83
Total Funding:
1.3 M EUR
Technology used in webpage:
Content Delivery Network Domain Not Resolving Amazon DigiCert SSL CloudFront OpenResty AWS Global Accelerator Encryption Everywhere
Investors List
BioInnovation Institute
BioInnovation Institute investment in Venture Round - RetiPharma
